Background/Aims: We consider the situation that multiple genetic variants are underlying a heritable trait and assume that each contributes to the trait only to a small degree. The aim is to develop a statistical test for disease association of these multiple variants. Methods: We expect that p values resulting from a genome-wide case-control association analysis will fall into two classes: those reflecting true association and those occurring randomly in the interval from 0 to 1. We develop a partition test to find the set of smallest p values deviating most from the number of p values expected under randomness. Results: Power calculations demonstrate the superiority of our partition test over conventional SNP-by-SNP analyses. Applications of the partition test to six published datasets show that our test is particularly suitable when multiple SNPs appear to contribute to a trait, and furnished more significant results than a well-known procedure to estimate the false discovery rate. Conclusions: Our partition test also furnishes an estimate of the number of functional SNPs underlying disease and can be highly significant, while single-locus tests may be far from significant.

Keywords:
Multilocus analysis, Case-control association test, False discovery rate, Multiple testing
This content is only available via PDF.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.